Neil Stinson

Asc. Director Pharmaceutical Technology at Purdue Pharma

Neil Stinson's work experience begins in 2001 at Atlantic Pharmaceutical Services Inc., where they worked as a Project Leader in Technical Services for contract manufacturing. Neil provided support in process development, scale-up, and commercial support, as well as interacting with clients and generating reports.

After that, Stinson worked at Shire Pharmaceuticals from 2002 to 2009 as a Sr. Process Development Engineer. Their responsibilities included performing Tech Transfers for Phase III Clinical products and commercial products, as well as developing PAT solutions for Shire products.

In 2009, Stinson joined Rhodes Pharmaceuticals, which is a subsidiary of Purdue Pharma LP, as a Sr. Technical Services Specialist. Neil stayed with the company until 2010 before moving to Sandoz Pharmaceuticals, where they worked as a Scientist in IV Technical Services for a year.

Stinson returned to Purdue Pharma LP in 2011, this time as a Sr. Technical Services Specialist. Neil then progressed to the role of Sr. Manager Validation and Technical Services in 2012, where their primary goals were to perform life cycle management, risk mitigation, and process optimization for commercial products.

Finally, Stinson took on the role of Associate Director of Pharmaceutical Technology at Purdue Pharma LP in 2015. In this position, they provided leadership to pharmaceutical scientists and programs, overseeing process qualification in all three phases, and representing technical operations/manufacturing in various areas such as clinical manufacturing, process development, and commercial support.

Neil Stinson attended York College of Pennsylvania from 2005 to 2008, where they earned a Master of Business Administration (MBA) degree in the field of study of Business. Prior to that, they studied at PennWest Clarion from 1996 to 2000 and obtained a Bachelor of Science (BS) degree in Biology.

Links

Previous companies

Sandoz logo


Teams

This person is not in any teams